News|Articles|April 30, 2020

In the Lab eNewsletter

  • Pharmaceutical Technology's In the Lab eNewsletter-05-06-2020
  • Volume 15
  • Issue 5

Primera Technology Presents Signature Slide and Cassette Printers

The new printers contain integrated PTLab software and can print directly onto slides and cassettes, eliminating handwritten mistakes and expensive labels.

Primera Technology presents its Signature Slide and Cassette Printers with integrated PTLab software, which can significantly increase lab efficiency while helping to reduce the risk of specimen misidentification.

Labs can use the printers to print directly onto slides and cassettes, eliminating handwriting mistakes or expensive and difficult-to-apply labels. The printer can handle text, graphics, and logos, along with linear and 2D bar codes, making workflow more efficient while increasing patient safety, according to Primera Technology.

Features and benefits include:

  • On-demand, black, or color printing

  • Prints directly on slides and cassettes-eliminates handwriting or difficult-to-apply labels

  • Chemical-resistant ink-ensures reliable identification of slides or cassettes

  • PTLab Software-included software ensures that the exact information required gets printed each time; optional Pro version allows configurable input/output data streams to laboratory information systems

  • Small footprint-slide printer and manual cassette printer are well fit for the workstation space

  • Reduced inventory and purchasing activity-inventory of multiple slide colors and cassettes can be eliminated because printer can print in colors

  • Thermal-transfer printing at 300 dpi for sharp resolution

  • On-demand or batch mode printing

Source: Primera Technology


Related to this article

PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.